Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors

被引:19
|
作者
Kanamori, Masayuki [1 ]
Kumabe, Toshihiro [1 ]
Sonoda, Yukihiko [1 ]
Nishino, Yoshikazu [2 ]
Watanabe, Mika [3 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
Oligodendroglioma; Dissemination; Predictive factors; Nestin Ki-67; LOW-GRADE OLIGODENDROGLIOMAS; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; GLIOMAS; CHEMOTHERAPY; RADIOTHERAPY; MARKERS; NESTIN;
D O I
10.1007/s11060-008-9762-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O-6-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index a parts per thousand yen 25%, diffuse expression of nestin, and p53 labeling index a parts per thousand yen 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index a parts per thousand yen 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [31] Overall Survival: A Gold Standard in Search of a Surrogate The Value of Progression-Free Survival and Time to Progression as End Points of Drug Efficacy
    Zhuang, Sen H.
    Xiu, Liang
    Elsayed, Yusri A.
    CANCER JOURNAL, 2009, 15 (05) : 395 - 400
  • [32] Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer
    Shimokawa, M.
    Ohki, M.
    Kaku, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (04) : 370 - 375
  • [33] Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
    Taniguchi, Yoshihiko
    Tamiya, Akihiro
    Isa, Syun-Ichi
    Nakahama, Kenji
    Okishio, Kyoichi
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Inoue, Takako
    Tamiya, Motohiro
    Hirashima, Tomonori
    Imamura, Fumio
    Atagi, Shinji
    ANTICANCER RESEARCH, 2017, 37 (10) : 5857 - 5862
  • [34] Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
    Hess, Lisa M.
    Brnabic, Alan
    Mason, Oksana
    Lee, Pablo
    Barker, Scott
    JOURNAL OF CANCER, 2019, 10 (16): : 3717 - 3727
  • [35] Progression-Free Survival as a Predictor of Overall Survival in Metastatic Renal Cell Carcinoma Treated With Contemporary Targeted Therapy
    Heng, Daniel Y. C.
    Xie, Wanling
    Bjarnason, Georg A.
    Vaishampayan, Ulka
    Tan, Min-Han
    Knox, Jennifer
    Donskov, Frede
    Wood, Lori
    Kollmannsberger, Christian
    Rini, Brian I.
    Choueiri, Toni K.
    CANCER, 2011, 117 (12) : 2637 - 2642
  • [36] 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
    Costelloe, Colleen M.
    Macapinlac, Horner A.
    Madewell, John E.
    Fitzgerald, Nancy E.
    Mawlawi, Osama R.
    Rohren, Eric M.
    Raymond, A. Kevin
    Lewis, Valerae O.
    Anderson, Peter M.
    Bassett, Roland L., Jr.
    Harrell, Robyn K.
    Marom, Edith M.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (03) : 340 - 347
  • [37] Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma
    Lacedonia, Donato
    Landriscina, Matteo
    Scioscia, Giulia
    Tondo, Pasquale
    Caccavo, Incoronata
    Bruno, Giuseppina
    Giordano, Guido
    Piscazzi, Annamaria
    Foschino Barbaro, Maria Pia
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [38] Therapeutic effect of apatinib on overall survival is mediated by prolonged progression-free survival in advanced gastric cancer patients
    Huang, Lihong
    Wei, Yongyue
    Shen, Sipeng
    Shi, Qianwen
    Bai, Jianling
    Li, Jin
    Qin, Shukui
    Yu, Hao
    Chen, Feng
    ONCOTARGET, 2017, 8 (17) : 29346 - 29354
  • [39] Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis
    Wang, Jingnan
    Liu, Xin
    Wu, Yunpeng
    Zhong, Qiuzi
    Wu, Tao
    Yang, Yong
    Chen, Bo
    Jing, Hao
    Tang, Yuan
    Jin, Jing
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Lu, Ningning
    Li, Ning
    Zhai, Yirui
    Zhang, Wenwen
    Deng, Min
    Wang, Shulian
    Chen, Fan
    Yin, Lin
    Hu, Chen
    Qi, Shunan
    Li, Yexiong
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (03): : 249 - 259
  • [40] Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
    Kohei Shitara
    Junko Ikeda
    Tomoya Yokota
    Daisuke Takahari
    Takashi Ura
    Kei Muro
    Keitaro Matsuo
    Investigational New Drugs, 2012, 30 : 1224 - 1231